Bio-Gene Technology Ltd (ASX:BGT)
Share Pricing & News Technology

AUD 0.125

-0.005 (3.846%)
(As on 2022-08-09 19:55:29 AEDT)
Previous Close Open Close*
0.13 0.13 0.125
Market Cap Dividend Yield (Annualized)
AUD 22.129M 0.00%

Day Range
0.125L 0.13 H
0.11L 0.35 H

Chart Price & Information

Last Trade 0.125
Change% -3.8462
52 W H/L 0.350/0.110
EBITDA -2.538M
NPAT After Abnormal Items -2.396M
Equity 4.246M
ROE% -56.43%
Total Liabilities 754,573
Total Revenue 604,085
Cash and Cash Equivalents 3.933M

Stock Information

Share price 0.125
Market Cap 22.129M
Price/Gross Cash Flow -15.83
Dividend Yield Excluding Special 0.00%
Ending Shares 153.633M
52-Week Range 0.350-0.110
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.03
P/E ratio 0.000
Sector P/E --
EPS -1.75
Net Profit Margin (%) -418.11%
Gross Cash Flows Per Share -0.01
Net Gearing -92.63%
Sales Per Share 0.00
Book Value Per Share 0.03

Similar Companies

Related Articles

About Company

Bio-Gene Technology Limited (ASX: BGT), incorporated in 1995, is a biotechnology company in Australia that is engaged in the development of insecticides. It first discovered the insecticidal activity of ?-triketone chemical class followed by a botanical screening program. It aims at identifying natural product-based insecticides in Australian flora. It is into the development of two products: Qcide and Flavocide.

Corporate Information

Level 6, 400 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000

Phone:03 9068 1062



Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-02-16 2023
Report (Annual) 2022-08-25 2022
Report (Prelim) 2022-08-25 2022